PROVIDER PROFILE · NPI 1508008574
Matthew KanaanDO , MS
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
675
Unique beneficiaries
—
Total services
1,827
Distinct HCPCS
12
Medicare payment
$106K
Peer benchmark
Total Medicare services vs. 74 Sports Medicine providers in NC — below median (cohort median 3,538).
PRESCRIBING · PART D · 2024
Total Rx claims
63
Beneficiaries
—
Total drug cost
$65
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Prednisone51 claims
Meloxicam12 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$4K
Payment records
8
By payment type
Consulting Fee$4K
Food and Beverage$414
Top paying entities
Consulting Fee$4K
Food and Beverage$414
REFERRAL NETWORK
Where Matthew Kanaan's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 5 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Stuart Levin Internal Medicine · Raleigh, NC | 26 | 88 |
| REX HOSPITAL INC. | 26 | 65 |
| Curtis Carlson Internal Medicine · Raleigh, NC | 17 | 79 |
| Rodger Israel Internal Medicine · Raleigh, NC | 13 | 66 |
| Arvind Jariwala Family Practice · Raleigh, NC | 11 | 65 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Burlington, NC | 24 | 50 |
| REX HOSPITAL INC. | 23 | 53 |
| Stuart Levin Internal Medicine · Raleigh, NC | 13 | 36 |
| Rodger Israel Internal Medicine · Raleigh, NC | 11 | 30 |
| NPI 1902891997 | 11 | 48 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE